In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

WCK 771 demonstrated MIC(50) and MIC(90)s of 0.03 and 1 microg/ml, respectively, against 297 recent U.S. community-acquired and hospital strains of Staphylococcus aureus, irrespective of quinolone or glycopeptide resistance. Against quinolone-resistant strains, MIC(90)s of WCK 771 and moxifloxacin were 1 and 16 microg/ml, respectively.

Knowledge Graph

Similar Paper

In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types
Antimicrobial Agents and Chemotherapy 2009.0
Antistreptococcal Activity of AR-709 Compared to That of Other Agents
Antimicrobial Agents and Chemotherapy 2008.0
WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections
Bioorganic & Medicinal Chemistry Letters 2022.0
Activity of the Diaminopyrimidine AR-709 against Recently Collected Multidrug-Resistant Isolates of Invasive Streptococcus pneumoniae from North America
Antimicrobial Agents and Chemotherapy 2008.0
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus
Bioorganic & Medicinal Chemistry Letters 2007.0
Antistaphylococcal Activity of CG400549, a New Experimental FabI Inhibitor, Compared with That of Other Agents
Antimicrobial Agents and Chemotherapy 2007.0
Antibacterial activity of quinolone–Macrocycle conjugates
Bioorganic & Medicinal Chemistry Letters 2003.0
In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone
Antimicrobial Agents and Chemotherapy 2010.0
In Vitro Activity of DC-159a, a New Broad-Spectrum Fluoroquinolone, Compared with That of Other Agents against Drug-Susceptible and -Resistant Pneumococci
Antimicrobial Agents and Chemotherapy 2008.0
WCK 4034: A promising oxazolidinone for treating gram positive infections
Bioorganic & Medicinal Chemistry Letters 2022.0